Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Combining a compound from broccoli with an antimalarial drug prevents prostate cancer in mice, University of Pittsburgh Cancer Institute (UPCI) researchers discovered.
The National Cancer Institute-funded research will be published in the Oct. 1 issue of the journal Cancer Research. It is the first such study to show the effectiveness of the combined treatment and provides compelling evidence for human clinical trials.
"Men with prostate cancer suffer significant impairments in quality of life, not only from the disease itself, but also from the treatments," said senior author Shivendra Singh, Ph.D., professor in Pitt's Department of Pharmacology & Chemical Biology. "Because the predominant risk factors for prostate cancer, such as age, race and genetics, cannot be avoided, there is a great need for preventative treatments for those most at risk."
Cruciferous vegetables, such as broccoli, watercress and cabbage, are associated with a lower risk of prostate cancer. The phytochemical sulforaphane in cruciferous vegetables is believed to be responsible.
When scientists tested sulforaphane in the lab, they found it works to prevent early-stage prostate cancer, but not late-stage. Dr. Singh and his colleagues hypothesized that this was due to a cellular mechanism called autophagy, which limits the ability of drugs to destroy cancer.
The antimalarial drug chloroquine inhibits autophagy. When chloroquine and sulforaphane were given to mice predisposed to prostate cancer, only 12 percent of the mice developed late-stage prostate cancer, compared to half in the control group.
"These results are very promising, but I do not recommend that men take chloroquine while eating broccoli in an attempt to prevent prostate cancer," said Dr. Singh. "Certainly eating broccoli and other cruciferous vegetables is good for you, but chloroquine can have side effects, and it has not been tested in humans for the purpose of preventing prostate cancer."
Additional researchers on this study include Avani R. Vyas, Ph.D., Eun-Ryeong Hahm, Ph.D., Simon Watkins, Ph.D., and Donna Beer Stolz, Ph.D., all of the University of Pittsburgh; and Dhimant Desai, Ph.D., Shantu Amin, Ph.D., both of the Penn State Milton S. Hershey Medical Center.
This research was supported by the National Cancer Institute grant RO1 CA115498-07.
University of Pittsburgh Cancer Institute
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Prostate / Prostate Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Pittsburgh Cancer Institute. "Unusual combination therapy shows promise for preventing prostate cancer, UPCI researchers find." Medical News Today. MediLexicon, Intl., 18 Sep. 2013. Web.
11 Dec. 2013. <http://www.medicalnewstoday.com/releases/266239>
University of Pittsburgh Cancer Institute. (2013, September 18). "Unusual combination therapy shows promise for preventing prostate cancer, UPCI researchers find." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266239.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.